BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19327634)

  • 1. Current therapy for isolated toxoplasmic lymphadenopathy.
    Anton E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):450; author reply 450. PubMed ID: 19327634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of toxoplasmosis].
    van der Veen J
    Ned Tijdschr Geneeskd; 1979 Apr; 123(14):564-6. PubMed ID: 431741
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
    Faucher B; Moreau J; Zaegel O; Franck J; Piarroux R
    J Antimicrob Chemother; 2011 Jul; 66(7):1654-6. PubMed ID: 21459896
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
    Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
    J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
    Soheilian M; Ramezani A; Azimzadeh A; Sadoughi MM; Dehghan MH; Shahghadami R; Yaseri M; Peyman GA
    Ophthalmology; 2011 Jan; 118(1):134-41. PubMed ID: 20708269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxoplasmic lymphadenitis].
    Kobayashi H
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):335-7. PubMed ID: 9851154
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
    Gilman TM; Boylen CT; Sattler FR
    Clin Pharm; 1989 Feb; 8(2):84, 87. PubMed ID: 2645082
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxoplasmosis and horse meat, France.
    Pomares C; Ajzenberg D; Bornard L; Bernardin G; Hasseine L; Darde ML; Marty P
    Emerg Infect Dis; 2011 Jul; 17(7):1327-8. PubMed ID: 21762609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
    Leport C; Vildé JL; Katlama C; Regnier B; Mathéron S; Saimot AG
    Ann Med Interne (Paris); 1987; 138(1):30-3. PubMed ID: 3592453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current therapy of clinically manifested toxoplasmose in adults. Is there the possibility of active immunization against toxoplasmosis?].
    Germer WD
    Med Welt; 1977 Oct; 28(43):1778. PubMed ID: 927148
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
    Djurkovic-Djakovic O; Romand S; Nobrè R; Couvreur J; Thulliez P
    Pediatr Infect Dis J; 2000 Jan; 19(1):81-3. PubMed ID: 10643858
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
    Lipka B; Milewska-Bobula B; Filipek M
    Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A young man with acute toxoplasmosis encephalitis].
    Lim BT; Carbaat PA; van Knapen F
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2086-7. PubMed ID: 3500422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
    Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF
    Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial.
    Alavi SM; Alavi L
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e67-9. PubMed ID: 20194044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of toxoplasmosis in obstetrics and gynecology].
    Furmaniuk J; Religa Z; Kiełek M; Siemiński R; Koszałkowski M; Szuba R; Walkowska I; Szymonik Z
    Ginekol Pol; 1981 Jan; 52(2):189-91. PubMed ID: 7250742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
    Langmann P; Klinker H; Richter E
    Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphadiazine-induced obstructive renal failure complicating treatment of HIV-associated toxoplasmosis.
    Allinson J; Topping W; Edwards SG; Miller RF
    Int J STD AIDS; 2012 Mar; 23(3):210-2. PubMed ID: 22581877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.